Experimental stem cells target devastating immune reactions
NCT ID NCT03123458
Summary
This early-stage study is testing whether infusions of specialized fetal stem cells can safely help control severe symptoms in people with serious immune-related disorders and tissue damage. The trial will enroll about 100 patients who have run out of other treatment options. Researchers aim to see if these cells can calm harmful immune reactions and stabilize patients' conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE RELATED DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aerospace Center Hospital
Beijing, 100049, China
-
Capital Institute of Pediatrics affiliated Children's hospital
Beijing, Beijing Municipality, 100020, China
-
Shenzhen Geno-immune Medical Institute
Shenzhen, Guangdong, 518000, China
Conditions
Explore the condition pages connected to this study.